These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15987932)

  • 1. Gestational exposure to lovastatin followed by cardiac malformation misclassified as holoprosencephaly.
    Edison RJ; Muenke M
    N Engl J Med; 2005 Jun; 352(26):2759. PubMed ID: 15987932
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system and limb anomalies in case reports of first-trimester statin exposure.
    Edison RJ; Muenke M
    N Engl J Med; 2004 Apr; 350(15):1579-82. PubMed ID: 15071140
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin drugs and congenital anomalies.
    Gibb H; Scialli AR
    Am J Med Genet A; 2005 Jun; 135(2):230-1; author reply 232-4. PubMed ID: 15810007
    [No Abstract]   [Full Text] [Related]  

  • 6. Bendectin and human congenital malformations.
    Shiono PH; Klebanoff MA
    Teratology; 1989 Aug; 40(2):151-5. PubMed ID: 2772850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holoprosencephaly and the teratogenicity of anticonvulsants.
    Holmes LB; Harvey EA
    Teratology; 1994 Feb; 49(2):82. PubMed ID: 8016748
    [No Abstract]   [Full Text] [Related]  

  • 9. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid embryopathy.
    Lammer EJ; Chen DT; Hoar RM; Agnish ND; Benke PJ; Braun JT; Curry CJ; Fernhoff PM; Grix AW; Lott IT
    N Engl J Med; 1985 Oct; 313(14):837-41. PubMed ID: 3162101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].
    Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A
    Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of malformations of the central nervous system: 1978-1988].
    Ramírez R; Nazer J; Hubner ME; Cifuentes L; Ruiz G; Pizarro MT; Parada L
    Rev Med Chil; 1990 May; 118(5):530-6. PubMed ID: 2293273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HMG-CoA reductase inhibitors and sexual dysfunction].
    Pía Iglesias G; Fernández Fernández FJ; Ameneiros Lago E; Sesma Sánchez P
    An Med Interna; 2001 Mar; 18(3):171. PubMed ID: 11594194
    [No Abstract]   [Full Text] [Related]  

  • 14. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects.
    Werler MM; Mitchell AA; Shapiro S
    N Engl J Med; 1989 Dec; 321(24):1639-42. PubMed ID: 2586566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins: beware during pregnancy.
    Prescrire Int; 2006 Feb; 15(81):18-9. PubMed ID: 16548110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holoprosencephaly in a Down syndrome child.
    Pi SY; Fineman RM; Wing SD; Grunnet M; Chan G
    Am J Med Genet; 1980; 5(2):201-6. PubMed ID: 6446857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
    Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
    Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holoprosencephaly as a possible embryonic alcohol effect.
    Ronen GM; Andrews WL
    Am J Med Genet; 1991 Aug; 40(2):151-4. PubMed ID: 1897567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of congenital cardiopathies].
    Becu L
    Arch Inst Cardiol Mex; 1972; 42(5):659-62. PubMed ID: 4653841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.